Read More

Why Is Cancer-Focused Janux Therapeutics Stock Trading Higher On Thursday?

Janux Therapeutics may be up for sale amid interest from major pharmaceutical firms. With shares quadrupling this year and a successful equity offering, Janux is making waves in the industry. The pharmaceutical industry has seen a surge in deal activities, with acquisitions totaling $27.8 billion since the year's start.

JANX